Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Swiatkiewicz, Iwona ^a   Kozinski, Marek ^a   Magielski, Przemyslaw ^a   Fabiszak, Tomasz ^a   Sukiennik, Adam ^a   Navarese, Eliano Pio ^a   Odrowaz Sypniewska, Grazyna ^a   Kubica, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CLOPIDOGREL; DIURETIC AGENT; HEPARIN; METOPROLOL; PERINDOPRIL; SIMVASTATIN; SPIRONOLACTONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE REMODELLING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; HEART INFARCTION; HEART VENTRICLE REMODELING; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; VENTRICULAR REMODELING;

EID: 84867774445     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/250867     Document Type: Article

References (38)

1. Cohn J. N., Ferrari R., Sharpe N., Cardiac remodeling-concepts and clinical implications: a consensus paper from an International Forum on Cardiac Remodeling. Journal of the American College of Cardiology 2000 35 3 569 582 2-s2.0-0034162004 10.1016/S0735-1097(99)00630-0 (Pubitemid 30167013)
2. Bolognese L., Neskovic A. N., Parodi G., Cerisano G., Buonamici P., Santoro G. M., Antoniucci D., Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002 106 18 2351 2357 2-s2.0-0037195160 10.1161/01.CIR.0000036014.90197.FA (Pubitemid 35244737)
3. Pfeffer M. A., Braunwald E., Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990 81 4 1161 1172 2-s2.0-0025266820 (Pubitemid 20119612)
4. Funaro S., La Torre G., Madonna M., Galiuto L., Scarà A., Labbadia A., Canali E., Mattatelli A., Fedele F., Alessandrini F., Crea F., Agati L., Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study. European Heart Journal 2009 30 5 566 575 2-s2.0-63349095437 10.1093/eurheartj/ehn529
5. Savoye C., Equine O., Tricot O., Nugue O., Segrestin B., Sautière K., Elkohen M., Pretorian E. M., Taghipour K., Philias A., Aumégeat V., Decoulx E., Ennezat P. V., Bauters C., Myocardial infarction in modern clinical practice (from the Remodelage Ventriculaire [REVE] Study Group). The American Journal of Cardiology 2006 98 9 1144 1149 2-s2.0-33750087284 10.1016/j.amjcard.2006.06.011 (Pubitemid 44584097)
6. Galiuto L., Garramone B., Scarà A., Rebuzzi A. G., Crea F., La Torre G., Funaro S., Madonna M., Fedele F., Agati L., The extent of microvascular damage during myocardial contyrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. Journal of the American College of Cardiology 2008 51 5 552 559 2-s2.0-38349190874 10.1016/j.jacc.2007. 09.051
7. Bolognese L., Carrabba N., Parodi G., Santoro G. M., Buonamici P., Cerisano G., Antoniucci D., Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004 109 9 1121 1126 2-s2.0-1542409911 10.1161/01.CIR.0000118496.44135.A7 (Pubitemid 38332616)
8. Frangogiannis N. G., Regulation of the inflammatory response in cardiac repair. Circulation Research 2012 110 1 159 173 2-s2.0-84855371090 10.1161/CIRCRESAHA.111.243162
9. Anzai T., Yoshikawa T., Shiraki H., Asakura Y., Akaishi M., Mitamura H., Ogawa S., C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997 96 3 778 784 2-s2.0-0030855262 (Pubitemid 27329609)
10. Nian M., Lee P., Khaper N., Liu P., Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research 2004 94 12 1543 1553 2-s2.0-3042702881 10.1161/01.RES.0000130526.20854.fa (Pubitemid 38856961)
11. Takahashi T., Anzai T., Kaneko H., Mano Y., Anzai A., Nagai T., Kohno T., Maekawa Y., Yoshikawa T., Fukuda K., Ogawa S., Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction. American Journal of Physiology 2010 299 6 H1795 H1804 2-s2.0-78649735144 10.1152/ajpheart.00001.2010
12. Schiele F., Meneveau N., Seronde M. F., Chopard R., Descotes-Genon V., Dutheil J., Bassand J. P., C-reactive protein improves risk prediction in patients with acute coronary syndromes. European Heart Journal 2010 31 3 290 297 2-s2.0-76349092028 10.1093/eurheartj/ehp273
13. Suleiman M., Khatib R., Agmon Y., Mahamid R., Boulos M., Kapeliovich M., Levy Y., Beyar R., Markiewicz W., Hammerman H., Aronson D., Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein. Journal of the American College of Cardiology 2006 47 5 962 968 2-s2.0-33644589792 10.1016/j.jacc.2005.10.055
14. Fertin M., Hennache B., Hamon M., Ennezat P. V., Biausque F., Elkohen M., Nugue O., Tricot O., Lamblin N., Pinet F., Bauters C., Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 Study). American Journal of Cardiology 2010 106 10 1410 1416 2-s2.0-78149465123 10.1016/j.amjcard.2010.06.071
15. Orn S., Manhenke C., Ueland T., Dams J. K., Mollnes T. E., Edvardsen T., Aukrust P., Dickstein K., C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. European Heart Journal 2009 30 10 1180 1186 2-s2.0-66249137776 10.1093/eurheartj/ehp070
16. Arruda-Olson A. M., Enriquez-Sarano M., Bursi F., Weston S. A., Jaffe A. S., Killian J. M., Roger V. L., Left ventricular function and C-reactive protein levels in acute myocardial infarction. American Journal of Cardiology 2010 105 7 917 921 2-s2.0-77949549053 10.1016/j.amjcard.2009.11.025
17. Schiller N. B., Shah P. M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Journal of the American Society of Echocardiography 1989 2 5 358 367 2-s2.0-0024723470
18. Lang R. M., Bierig M., Devereux R. B., Flachskampf F. A., Foster E., Pellikka P. A., Picard M. H., Roman M. J., Seward J., Shanewise J., Solomon S., Spencer K. T., John S. M. S., Stewart W., Recommendations for chamber quantification. European Journal of Echocardiography 2006 7 2 79 108 2-s2.0-32944459711 10.1016/j.euje.2005.12.014 (Pubitemid 43257193)
19. Devereux R. B., Alonso D. R., Lutas E. M., Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. The American Journal of Cardiology 1986 57 6 450 458 2-s2.0-0022588019 (Pubitemid 16119719)
20. Mather A. N., Fairbairn T. A., Artis N. J., Greenwood J. P., Plein S., Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. International Journal of Cardiology. In press 2-s2.0-81555232803 10.1016/j.ijcard.2011.11.004
21. Bonvini R. F., Hendiri T., Camenzind E., Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target? European Heart Journal, Supplement 2005 7 supplement I I27 I36 2-s2.0-26844470359 10.1093/eurheartj/sui077
22. Minatoguchi S., Takemura G., Chen X. H., Wang N., Uno Y., Koda M., Arai M., Misao Y., Lu C., Suzuki K., Goto K., Komada A., Takahashi T., Kosai K., Fujiwara T., Fujiwara H., Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004 109 21 2572 2580 2-s2.0-2642517975 10.1161/01.CIR.0000129770.93985.3E (Pubitemid 38720559)
23. Kitsis R. N., Jialal I., Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein. The New England Journal of Medicine 2006 355 5 513 515 2-s2.0-33746736963 10.1056/NEJMcibr063197 (Pubitemid 44162281)
24. Pepys M. B., Hirschfield G. M., Tennent G. A., Gallimore J. R., Kahan M. C., Bellotti V., Hawkins P. N., Myers R. M., Smith M. D., Polara A., Cobb A. J. A., Ley S. V., Aquilina J. A., Robinson C. V., Sharif I., Gray G. A., Sabin C. A., Jenvey M. C., Kolstoe S. E., Thompson D., Wood S. P., Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006 440 7088 1217 1221 2-s2.0-33646366683 10.1038/nature04672
25. Lagrand W. K., Niessen H. W. M., Wolbink G. J., Jaspars L. H., Visser C. A., Verheugt F. W. A., Meijer C. J. L. M., Hack C. E., C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997 95 1 97 103 2-s2.0-0031022737 (Pubitemid 27029949)
26. Griselli M., Herbert J., Hutchinson W. L., Taylor K. M., Sohail M., Krausz T., Pepys M. B., C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. The Journal of Experimental Medicine 1999 190 12 1733 1739 2-s2.0-0033396705 10.1084/jem.190.12.1733 (Pubitemid 30013840)
27. Abbate A., Biondi-Zoccai G. G. L., Bussani R., Dobrina A., Camilot D., Feroce F., Rossiello R., Baldi F., Silvestri F., Biasucci L. M., Baldi A., Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. Journal of the American College of Cardiology 2003 41 5 753 760 2-s2.0-0037420098 10.1016/S0735-1097(02)02959-5 (Pubitemid 36308381)
28. Roes S. D., Kelle S., Kaandorp T. A. M., Kokocinski T., Poldermans D., Lamb H. J., Boersma E., van der Wall E. E., Fleck E., de Roos A., Nagel E., Bax J. J., C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion. The American Journal of Cardiology 2007 100 6 930 936 2-s2.0-34548415378 10.1016/j.amjcard.2007.04.029 (Pubitemid 47368098)
29. Barrett T. D., Hennan J. K., Marks R. M., Lucchesi B. R., C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion. Journal of Pharmacology and Experimental Therapeutics 2002 303 3 1007 1013 2-s2.0-0036896917 10.1124/jpet.102.040600 (Pubitemid 35424383)
30. Ohlmann P., Jaquemin L., Morel O., El Behlgiti R., Faure A., Michotey M. O., Beranger N., Roul G., Schneider F., Bareiss P., Monassier J. P., Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction. American Heart Journal 2006 152 6 1161 1167 2-s2.0-33845214096 10.1016/j.ahj.2006.07.016 (Pubitemid 44854795)
31. Haase J., Bayar R., Hackenbroch M., Störger H., Hofmann M., Schwarz C. E., Reinemer H., Schwarz F., Ruef J., Sommer T., Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. Journal of Interventional Cardiology 2004 17 6 367 373 2-s2.0-9244263004 10.1111/j.1540-8183.2004.04078.x (Pubitemid 39552591)
32. Richards A. M., Nicholls M. G., Espiner E. A., Lainchbury J. G., Troughton R. W., Elliott J., Frampton C., Turner J., Crozier I. G., Yandle T. G., B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003 107 22 2786 2792 2-s2.0-0038120013 10.1161/01.CIR.0000070953.76250.B9 (Pubitemid 36705987)
33. Cerisano G., Pucci P. D., Sulla A., Tommasi M., Raspanti S., Santoro G. M., Antoniucci D., Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodelling after reperfused acute myocardial infarction. The American Journal of Cardiology 2007 99 5 651 656 2-s2.0-33847027970 10.1016/j.amjcard.2006.09.114
34. Garcia-Alvarez A., Sitges M., Delgado V., Ortiz J., Vidal B., Poyatos S., de Caralt T. M., Heras M., Bosch X., Azqueta M., Pare C., Brugada J., Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. The American Journal of Cardiology 2009 104 7 878 882 2-s2.0-70249120394 10.1016/j.amjcard. 2009.05.025
35. Scirica B. M., Sabatine M. S., Jarolim P., Murphy S. A., De Lemos J. L., Braunwald E., Morrow D. A., Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 Trial. European Heart Journal 2011 32 6 697 705 2-s2.0-79952849795 10.1093/eurheartj/ehq468
36. Giannuzzi P., Temporelli P. L., Bosimini E., Gentile F., Lucci D., Maggioni A. P., Tavazzi L., Badano L., Stoian I., Piazza R., Heyman I., Levantesi G., Cervesato E., Geraci E., Nicolosi G. L., Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy. American Heart Journal 2001 141 1 131 138 2-s2.0-0035163438 10.1067/mhj.2001.111260 (Pubitemid 32061323)
37. Alpert M. A., Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. American Journal of the Medical Sciences 2001 321 4 225 236 2-s2.0-0035064965 (Pubitemid 32275931)
38. Thakker G. D., Frangogiannis N. G., Bujak M., Zymek P., Gaubatz J. W., Reddy A. K., Taffet G., Michael L. H., Entman M. L., Ballantyne C. M., Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. American Journal of Physiology 2006 291 5 H2504 H2514 2-s2.0-33751197725 10.1152/ajpheart.00322.2006